Monday, May 10, 2021
Home Life Style Health & Fitness Prostate Drug May Lower Parkinson's Disease Risk In Men

Prostate Drug May Lower Parkinson’s Disease Risk In Men

The studies found that a longer duration of use of the energy-enhancing prostate drugs was associated with increased protective effects

Taking a particular type of medication to treat an enlarged prostate is associated with a reduced risk of developing Parkinson’s disease among men, a new study suggests. The findings, published in the journal JAMA Neurology, provide compelling evidence that terazosin, and similar medications, might have the potential to prevent or delay the development of Parkinson’s disease.

“Men taking terazosin were 12 percent to 37 percent less likely to develop Parkinson’s disease during follow-up than men taking tamsulosin,” said Jacob Simmering, Assistant Professor at the University of Iowa in the US. The findings build on previous preclinical research by the team, which showed that terazosin enhances cellular energy levels and can prevent or slow the progression of Parkinson’s disease in animal models.

Follow NewsGram on Twitter to stay updated about the World news.

In this earlier study, the team also used the Truven database to show that men with Parkinson’s disease who were also taking terazosin and the related prostate drug had reduced signs, symptoms, and complications of Parkinson’s disease.

ALSO READ: Study: Keeping Plants At Home Can Keep You Mentally Healthy

Tamsulosin is another prostate drug commonly used to treat an enlarged prostate, but unlike terazosin, tamsulosin has no effect on cellular energy production, which the team’s lab studies suggest is important in terazosin’s protective effect. The new study extends these findings to investigate whether terazosin and related drugs that can also enhance cellular energy production are associated with a reduced risk of developing Parkinson’s disease.

For the study, the team identified 150,000 men newly started on terazosin or similar medications and matched them, based on age and clinical history to 150,000 men newly started on tamsulosin. Additionally, the study found that a longer duration of use of the energy-enhancing prostate drugs was associated with increased protective effects. (IANS)

STAY CONNECTED

19,511FansLike
362FollowersFollow
1,773FollowersFollow

Most Popular

Knowledge Sharing Social Media Platform For Medical Students: MedBound

We've already been using major social networking sites for different purposes. Well, there are also some social networking sites that aren't to be missed...

Covid19 In India Brought Automation Technologies And IA To The Forefront

The Covid-19 pandemic has brought automation technologies to the forefront and the Intelligent Automation (IA) market in India is estimated to grow at a...

Corset: A Brief History

By- Khushi Bisht Corsets have existed for a very long time. It first originated in Italy and was brought to France in the 16th century...

Hybrid Work Is The Next Big Disruption In US Society

By Dora Mekouar Hybrid schedules could be the next monumental shift in the American workplace after last year's sudden move to remote work. More than 70%...

An Overview Of Bipolar Disorder

BY- JAYA CHOUDHARY Bipolar disorder, also known as bipolar depressive disorder, is a neurological disorder that causes mood and behavior changes. Bipolar disorder is characterized...

Cancer Immunotherapy Approach Targets Common Genetic Alteration

By Blake Jones Researchers have found a prototype for a new kind of immunotherapy for cancer. This therapy uses modified T-cells to target and attack...

Outlook Into Wellness Tourism Growth During Pandemic

The roller coaster ride that was 2020 brought the biggest dip in modern history, forcing individuals to adapt to major lifestyle changes while the...

Strengthen Your Immune System Against Foreign Pathogens

At the personal level, the fight against the Covid-19 virus begins with strong immunity. As the second wave turns out to be more alarming...

Recent Comments